Trial Search Results

Edwards CLASP TR EFS

Early feasibility study to assess the safety and performance of the Edwards PASCAL Transcatheter Valve Repair System in tricuspid regurgitation

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Edwards Lifesciences

Stanford Investigator(s):

Intervention(s):

  • Device: Transcatheter Tricuspid Valve Repair

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Severe functional or degenerative TR

   - Symptomatic despite medical therapy

   - The local site Heart Team determines that the patient is appropriate for transcatheter
   tricuspid valve repair

Exclusion Criteria:

   - Unsuitable anatomy

   - Previous tricuspid valve repair or replacement

   - Co-morbid condition(s) that, in the opinion of the investigator, could limit the
   patient's ability to participate in the study, including compliance with follow-up
   requirements, or that could impact the scientific integrity of the study

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Recruiting